REGISTERED NUMBER: 06151049 (England and Wales)

Report of the Directors and

Financial Statements for the Year Ended 31 December 2024

for

pfm medical UK Limited

Page

Report of the Directors

1

Balance Sheet

2

Notes to the Financial Statements

3

The directors present their report with the financial statements of the company for the year ended 31 December 2024.

PRINCIPAL ACTIVITY

The principal activity of the company in the year under review was that of the sale of Medical Equipment to the Healthcare Industry.

DIRECTORS

The directors shown below have held office during the whole of the period from 1 January 2024 to the date of this report.

Mr D J Haykin

Mr F Klinker

STATEMENT OF DIRECTORS' RESPONSIBILITIES

The directors are responsible for preparing the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law), including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-	select suitable accounting policies and then apply them consistently;

-	make judgements and accounting estimates that are reasonable and prudent;

-	prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS

So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS

The auditors, Harts Limited, will be proposed for re-appointment at the forthcoming Annual General Meeting.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:

Mr F Klinker - Director

22 July 2025

FIXED ASSETS

Tangible assets

4

12,323

24,798

CURRENT ASSETS

Stocks

1,388,503

884,363

Debtors

5

843,937

941,605

Cash at bank

869,469

1,304,552

3,101,909

3,130,520

CREDITORS

Amounts falling due within one year

6

(916,147

)

(1,314,513

)

NET CURRENT ASSETS

2,185,762

1,816,007

TOTAL ASSETS LESS CURRENT LIABILITIES

2,198,085

1,840,805

CAPITAL AND RESERVES

Called up share capital

7

590,000

590,000

Retained earnings

1,608,085

1,250,805

SHAREHOLDERS' FUNDS

2,198,085

1,840,805

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 22 July 2025 and were signed on its behalf by:

Mr F Klinker - Director

1.	STATUTORY INFORMATION

pfm medical UK Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

06151049

Registered office:

Suite 3

Armcon Business Park

London Road South

Poynton

Cheshire

SK12 1LQ

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover from the sale of goods is recognised when significant risks and rewards of ownership of the goods have transferred to the buyer, the amount of turnover can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transaction can be measured reliably. This is usually on delivery of the goods.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Improvements to property

-

Straight line over the 5 years of lease

Fixtures and fittings

-

Straight line over 7 years

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Foreign currencies

Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 25 (2023 - 26 ) .

4.	TANGIBLE FIXED ASSETS

Improvements

Fixtures

to

and

property

fittings

Totals

£

£

£

COST

At 1 January 2024

and 31 December 2024

54,026

56,991

111,017

DEPRECIATION

At 1 January 2024

48,964

37,255

86,219

Charge for year

4,333

8,142

12,475

At 31 December 2024

53,297

45,397

98,694

NET BOOK VALUE

At 31 December 2024

729

11,594

12,323

At 31 December 2023

5,062

19,736

24,798

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.24

31.12.23

£

£

Trade debtors

708,758

796,130

Other debtors

135,179

145,475

843,937

941,605

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.24

31.12.23

£

£

Trade creditors

111,762

41,634

Amounts owed to group undertakings

201,110

531,188

Taxation and social security

338,038

410,231

Other creditors

265,237

331,460

916,147

1,314,513

7.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31.12.24

31.12.23

value:

£

£

590,000

Ordinary shares

£1

590,000

590,000

8.	DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Melissa Bowers FCCA (Senior Statutory Auditor)

for and on behalf of Harts Limited

9.	ULTIMATE CONTROLLING PARTY

pfm Medical UK Limited is a 100% owned subsidiary of pfm Medical AG.

The registered office of pfm Medical AG is:

Wankelsbraße 60

50996 Köln

Germany